Literature DB >> 29189394

Ischemic stroke in liver cirrhosis: epidemiology, risk factors, and in-hospital outcomes.

Xintong Zhang1,2, Xingshun Qi1, Eric M Yoshida3, Nahum Méndez-Sánchez4, Feifei Hou1, Han Deng1, Xiaoxi Wang1, Jing Qiu5, Chao He5, Shuang Wang5,2, Xiaozhong Guo1.   

Abstract

BACKGROUND AND AIMS: Patients with cirrhosis are reportedly more prone to develop hemorrhagic stroke, thereby increasing the risk of death. However, the effect of ischemic stroke on liver diseases remains unclear. In addition, few studies have explored the risk factors for ischemic stroke in patients with liver cirrhosis. Our study aimed to explore the epidemiology, risk factors, and in-hospital outcomes of ischemic stroke in a large cohort of hospitalized patients with cirrhosis. PATIENTS AND METHODS: In this single-center observational study, we retrospectively reviewed the medical records of patients with liver cirrhosis admitted to our hospital from January 2011 to June 2014. A diagnosis of ischemic stroke was further identified.
RESULTS: Of the 2444 patients with liver cirrhosis, 160 had ischemic stroke, including 128 patients with previous ischemic stroke and 32 patients with new-onset ischemic stroke during their hospitalizations. Compared with patients with cirrhosis without ischemic stroke, those with ischemic stroke were significantly older; had a significantly higher proportion of arterial hypertension and a significantly lower proportion of hepatitis B virus infection; had significantly higher white blood cell, platelet, blood urea nitrogen, and triglyceride levels; and had significantly lower alanine aminotransferase and aspartate aminotransferase levels and prothrombin time. The in-hospital mortality was significantly higher in patients with ischemic stroke than in those without [8.80% (14/160) vs. 3.2% (72/2284), P=0.001].
CONCLUSION: Ischemic stroke was often observed in patients with cirrhosis, and it significantly increased the in-hospital mortality. The association of inflammation, coagulation disorders, and viral hepatitis with development of ischemic stroke in liver cirrhosis should be further evaluated in prospective cohort studies.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29189394     DOI: 10.1097/MEG.0000000000001011

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  3 in total

1.  Incorporation of Laboratory Test Biomarkers Into Dual Antiplatelet Therapy Score Improves Prediction of Ischemic and Bleeding Events in Post-percutaneous Coronary Intervention Patients.

Authors:  Chengming Sun; Lin Zhong; Yanqiu Wu; Chengfu Cao; Danjie Guo; Jie Liu; Lei Gong; Shouxin Zhang; Jun Sun; Yingqi Yu; Weiwei Tong; Jun Yang
Journal:  Front Cardiovasc Med       Date:  2022-05-16

2.  Prognostic Analysis of Liver Cirrhosis Patients with Cerebral Infarction and/or Gastrointestinal Hemorrhage: A Retrospective Cohort Study.

Authors:  Dianqiang Lu; Zhengyan Jiang; Xuezhen Zhai; Zhiguang Sun
Journal:  Comput Math Methods Med       Date:  2022-08-04       Impact factor: 2.809

3.  Stroke Induces Prolonged Changes in Lipid Metabolism, the Liver and Body Composition in Mice.

Authors:  Michael J Haley; Claire S White; Daisy Roberts; Kelly O'Toole; Catriona J Cunningham; Jack Rivers-Auty; Conor O'Boyle; Conor Lane; Oliver Heaney; Stuart M Allan; Catherine B Lawrence
Journal:  Transl Stroke Res       Date:  2019-12-21       Impact factor: 6.829

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.